B · Normal
[China Medicine: Pemafibrate Chemical API Marketing Application Approved] On November 16, China Pharmaceuticals (600056.SH) announced that Tianfang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the "Pemafibrate Chemical API Marketing Application Approval Notice" approved and issued by the State Food and Drug Administration. This medicine is used for adult patients with non-familial hypertriglyceridemia on the basis of diet control to reduce triglyceride levels.
A-share announcement express 🕐 2026-11-16 17:08

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet